Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Tharimmune ( (THAR) ) is now available.
On June 13, 2025, Tharimmune, Inc. entered into a securities purchase agreement with accredited investors for a private placement of common stock and warrants. The transaction, expected to close on June 20, 2025, aims to raise approximately $2.5 million in gross proceeds, which will be used for clinical development and working capital.
The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.
More about Tharimmune
Average Trading Volume: 130,294
Technical Sentiment Signal: Sell
See more insights into THAR stock on TipRanks’ Stock Analysis page.